American International Group’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,498
Closed -$180K 2868
2024
Q1
$180K Buy
19,498
+735
+4% +$6.47K ﹤0.01% 2212
2023
Q4
$182K Sell
18,763
-75
-0.4% -$701 ﹤0.01% 2220
2023
Q3
$169K Buy
18,838
+6,543
+53% +$62.1K ﹤0.01% 2217
2023
Q2
$138K Sell
12,295
-635
-5% -$5.63K ﹤0.01% 2385
2023
Q1
$136K Buy
12,930
+257
+2% +$2.83K ﹤0.01% 2318
2022
Q4
$123K Buy
12,673
+320
+3% +$3.6K ﹤0.01% 2412
2022
Q3
$152K Buy
12,353
+433
+4% +$5.28K ﹤0.01% 2316
2022
Q2
$122K Buy
11,920
+1,115
+10% +$12.3K ﹤0.01% 2473
2022
Q1
$137K Sell
10,805
-760
-7% -$11.6K ﹤0.01% 2459
2021
Q4
$242K Buy
+11,565
New +$234K ﹤0.01% 2259

Other funds holding ENFN

American International Group's ENFN Position: Q2 2024 in Review

American International Group sold out of Enfusion, Inc. (ENFN) in Q2 2024, closing a stake of 19,498 shares — an estimated $180K sold.

American International Group first reported a position in ENFN in Q4 2021 and held it in 10 quarters. The position peaked at $242K in Q4 2021. 101 funds tracked by Wall St. Rank hold ENFN as of Q2 2024.

  • American International Group reported no remaining Enfusion, Inc. position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,498 Enfusion, Inc. shares in Q2 2024, an estimated $180K.
  • American International Group first reported a position in Enfusion, Inc. in Q4 2021 and held it in 10 quarters.
  • American International Group's Enfusion, Inc. position peaked at $242K in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.